Using ICG dye to guide treatment of facial birthmarks
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests whether a special dye called ICG can help doctors treat a type of facial birthmark called capillary lymphatic malformation (cLM) more effectively. It may help by showing the birthmark more clearly during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have not had any previous treatment for your birthmark.
- Your doctor has confirmed the birthmark is a capillary lymphatic malformation (cLM) using an MRI scan.
- You are able to come back for check-ups 3 to 6 months after treatment.
- Your birthmark is on the surface of the skin (superficial).
- You do not have an allergy to iodine.
- Your birthmark is not part of a larger syndrome (a condition that affects other parts of the body).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests using a special dye (indocyanine green, or ICG) to help surgeons find the correct “sentinel” lymph nodes during surgery in children with certain suspected tumors. If successful, it may improve how doctors remove and check lymph nodes while reducing the chance of missing important areas.
This trial tests a new way to use a dye called ICG (indocyanine green) that is inhaled like a mist. It may help doctors see and treat congenital lung malformations in children more clearly.
This study tests whether using a special fluorescent dye (ICG) during salvage laryngectomy can reduce the chance of a surgical “leak” (a fistula) in the throat area. If you’re having salvage surgery after prior radiation, it may help surgeons better see where to place tissue coverage to prevent complications.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This study tests whether giving a special dye (ICG) before minimally invasive liver surgery helps surgeons see tumors more clearly compared to using ultrasound alone. It’s for people who are already scheduled for keyhole liver surgery.
Hear when a new Lymphatic Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.